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Background: The purpose of this study is to evaluate the efficacy of composite doxorubicin-
loaded micelles for enhancing doxorubicin radiosensitivity in multicellular spheroids from a 
non-small cell lung cancer cell line.
Methods: A novel composite doxorubicin-loaded micelle consisting of polyethylene glycol-
polycaprolactone/Pluronic P105 was developed, and carrier-mediated doxorubicin accumulation 
and release from multicellular spheroids was evaluated. We used confocal laser scanning 
microscopy and flow cytometry to study the accumulation and efflux of doxorubicin from 
A549 multicellular spheroids. Doxorubicin radiosensitization and the combined effects of 
irradiation and doxorubicin on cell migration and proliferation were compared for the different 
doxorubicin delivery systems.
Results: Confocal laser scanning microscopy and quantitative flow cytometry studies both 
verified that, for equivalent doxorubicin concentrations, composite doxorubicin-loaded 
micelles significantly enhanced cellular doxorubicin accumulation and inhibited doxorubicin 
release. Colony-forming assays demonstrated that composite doxorubicin-loaded micelles are 
radiosensitive, as shown by significantly reduced survival of cells treated by radiation + composite 
micelles compared with those treated with radiation + free doxorubicin or radiation alone. 
The multicellular spheroid migration area and growth ability verified higher radiosensitivity 
for the composite micelles loaded with doxorubicin than for free doxorubicin.
Conclusion: Our composite doxorubicin-loaded micelle was demonstrated to have 
radiosensitization. Doxorubicin loading in the composite micelles significantly increased its 
cellular uptake, improved drug retention, and enhanced its antitumor effect relative to free 
doxorubicin, thereby providing a novel approach for treatment of cancer.
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Introduction
Lung cancer is the most common primary malignant tumor in humans and is the 
leading cause of cancer mortality in the world.1 Its occurrence is increasing in both 
developing and developed countries, and in the latter, lung cancer is the second most 
frequently occurring cancer in both men and women. However, treatment for lung 
cancer remains relatively ineffective, and the five-year survival rate for advanced 
disease is only 15%.2
The 2011 National Comprehensive Cancer Network guidelines for lung cancer 
state that radiation has a potential role in the treatment of all stages of lung cancer, as 
either definitive treatment or as palliative therapy. It is recommended that radiation 
oncology should form part of a multidisciplinary evaluation provided for all patients 
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who may benefit from definitive local therapy, particularly 
those with absolute or relative contraindications to surgery 
as determined by a thoracic surgeon.
Although recent years have witnessed the development 
of radiation physics, biology, and radiotherapy facilities, 
the efficacy of radiation therapy is still not satisfactory. 
Research on radiosensitization, with the aim of improving the 
sensitivity of tumor cells to radiation, has been extensive.3–5 
The ideal radiation sensitizer should significantly increase the 
efficacy of radiotherapy, but have little or no adverse effect 
on normal tissues. Antitumor drugs, such as doxorubicin, 
are widely used in cancer therapy. However, side effects, 
such as bone marrow suppression, heart toxicity, and 
mucositis, limit the use of cytotoxic antitumor drugs as 
radiosensitizers. To reduce the toxicity of these drugs 
and improve their therapeutic efficacy, various polymeric 
micelle systems have been designed as delivery vehicles. If 
these carriers could improve cellular uptake and retention 
of the delivered compound, radiosensitization might be 
achieved using smaller doses of chemotherapy drugs, thus 
lowering the risk of side effects. New drug carrier micelles 
have high stability and biocompatibility, via the enhanced 
permeability and retention effect of drugs towards tumor 
cells, with enhanced efficacy and reduced toxicity, and are 
capable of slow drug release.6–10 Hydrophobic drugs can be 
incorporated into the micelle by both chemical conjugation 
and physical entrapment.11
However, simple polymeric micelles may not provide 
a satisfactory effect. We have previously reported that the 
combination of polyethylene glycol (PEG), polycaprolactone 
(PCL), and Pluronic P105 significantly decreased cytotoxicity 
and intracellular accumulation of loaded doxorubicin in 
drug-resistant K562/ADR tumor cells.12 Moreover, we have 
previously discovered that composite micelles consisting 
of two kinds of polymers (PEG-PCL and P105), had a 
synergistic effect as drug carriers in overcoming or reversing 
multidrug resistance in drug-resistant tumor cells.13 We 
observed that doxorubicin-loaded PEG-PCL/P105 composite 
micelles were more cytotoxic towards K562/ADR cells than 
were doxorubicin-loaded PEG-PCL or P105 single micelles 
or doxorubicin solution.13
Non-small cell lung cancer is more common than small 
cell lung cancer, occurring in 85% of patients with the 
disease. For non-small cell lung cancer, adenocarcinoma is 
particularly prone to metastasis, and therefore the human 
lung adenocarcinoma A549 cell line was selected to model 
non-small cell lung cancer in this study. Moreover, most 
studies of therapeutic efficacy in lung cancer cells have 
been carried out in monolayer cultures.14,15 However, the 
spheroid model is a three-dimensional cell culture system 
that more closely resembles in vivo tumor cell growth 
and is more physiologically relevant than monolayer cell 
growth.16,17 Individual tumor cells growing under these 
conditions face different microenvironments depending 
on their position inside the three-dimensional framework 
of the spheroid.
In this study, composite doxorubicin-loaded micelles 
consisting of PEG-PCL/Pluronic P105 were developed. 
A549 multicellular spheroids were incubated with drug-
loaded micelles and irradiated. Confocal laser scanning 
microscopy was used to measure the intensity of doxorubicin 
fluorescence and the depth of doxorubicin penetration into 
the spheroids, and flow cytometry was used to quantitate 
the doxorubicin fluorescence signal intensity, because 
doxorubicin is a fluorescent compound and cellular 
doxorubicin incorporation can be measured. Colony-forming 
assays were used to evaluate the radiosensitivity of composite 
doxorubicin-loaded micelles following ionizing radiation. 
We also studied the combined effects of irradiation and 
composite doxorubicin-loaded micelle treatment on tumor 
cell migration and proliferation in a well defined three-
dimensional spheroid culture system.
This study aimed to radiosensitize non-small cell lung 
cancer multicellular spheroids using doxorubicin-encapsulated 
micelles to achieve reduced toxicity and a higher therapeutic 
effect. Radiosensitization by increased intracellular accumula-
tion and delayed drug release will facilitate screening for novel 
and effective radiosensitizers and development of improved 
radiosensitizer delivery in targeting systems.
Materials and methods
Reagents
Fibroblast growth factor and epidermal growth factor were 
purchased from PeprotechAsia (Rocky Hill, NJ). B27 was 
purchased from Invitrogen Corporation (Camarillo, CA). 
RPMI 1640 medium, phosphate-buffered saline, fetal bovine 
serum, and 0.25% trypsin were purchased from Gibco-
BRL (Gaithersburg, MD). Doxorubicin hydrochloride was 
obtained from Zhejiang Hisun Pharmaceutical Co, Ltd. 
MPEGs and ε-caprolactone were purchased from Sigma-
Aldrich (St Louis, MO). Pluronic P105 was a kind gift 
from the BASF Corporation (Ludwigshafen, Germany). 
Agarose was purchased from Bio Basic Inc (Markham, 
ON, Canada). MTT was from Shanghai Sangon Biological 
Engineering Technology and Service Co, Ltd (Shanghai, 
China). CH2Cl2, triethylamine, and other reagents were 
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of analytical grade and supplied by Huadong Medical 
(Hangzhou, China).
Cell line spheroids
The human A549 cell line was obtained from the Cancer 
Institute, Second Affiliated Hospital of School of Medicine, 
Zhejiang University, cultured in RPMI 1640 medium 
supplemented with 10% fetal calf serum, 5000 U/mL 
  penicillin, and 5 mg/mL streptomycin, and incubated at 37°C 
in a humidified atmosphere containing 5% CO2. Spheroid 
A549 cultures were formed from exponentially growing 
monolayers. Briefly, cells were trypsinized, and 5 × 106 cells 
were then seeded in 50 mL of growth medium supplemented 
with epidermal growth factor 20 ng/mL, basic fibroblast 
growth factor 10 ng/mL, and B27 (B27 and medium at a 1:50 
volume ratio) and agitated using a benchtop roller (Wheaton, 
Millville, NJ). The medium was changed every 2–3 days.
Synthesis and characterization  
of PEG-PCL diblock copolymers
PEG-PCL diblock copolymers were synthesized as 
previously described, with minor modifications.13,18 Briefly, 
ring-opening polymerization of ε-caprolactone in CH2CL2 
was induced using mPEG and calcium ammoniate as the 
macroinitiator and catalyst, respectively. Precipitates were 
obtained by adding cold methanol, collected by filtration, and 
vacuum dried at 40°C. The molecular weight of the diblock 
copolymer was determined by 1H nuclear magnetic resonance 
spectroscopy using the intensity of the terminal methoxy 
proton signal of mPEG at Q 3.39 ppm and the methylene 
proton signal of polycaprolactone at 2.31 ppm. The weight 
ratio of the repeated PEG-PCL units was calculated to be 
7.08 from the integral values of characteristic peaks, and the 
molecular weight was determined to be 19,278 Da. A similar 
molecular weight was also obtained by gel permeation 
chromatography.
Preparation of composite doxorubicin-
loaded micelles
As we have previously reported,13 polymeric micelles 
  containing doxorubicin were prepared according to the 
solvent evaporation method. Briefly, 3 mg doxorubicin was 
dissolved in 2 mL of CH2Cl2 in the presence of a triple molar 
ratio of triethylamine and stirred at 500 rpm for 4 hours 
at room temperature. PEG-poly(lactic-co-glycolic acid) 
(PLGA) and Pluronic 105 at a 1:5 ratio were then added 
and vortexed until completely dissolved. Following this, the 
organic solution containing the drug and polymer was added 
to 20 mL of distilled water with sonication. The mixture 
was stirred vigorously (10,000 rpm) for one hour, and then 
stirred slowly (200 rpm) overnight. Residual CH2Cl2 was 
removed by a rotary evaporator. The micelle solution was 
concentrated to 5 mL and filtered (using a 0.22 µm pore 
size) to eliminate polymer and doxorubicin aggregates. All 
procedures were carried out with protection from light.
Micelle characterization
The morphology of the micelles was observed under a 
Morgagni 268 D transmission electron microscope (FEI, 
Eindhoven, The Netherlands) and particle size was measured 
by dynamic light scattering (Malvern Nano ZS, Malvern, 
Worcestershire, UK). The unloaded drug was separated 
by a filtration membrane (Millipore, Bedford, MA), and 
analytical high-performance liquid chromatography (Agilent 
1100 system, Santa Clara, CA) was used to quantify the 
amount of doxorubicin. Drug entrapment efficiency was 
calculated as the amount of doxorubicin entrapped in the 
micelle with respect to total micellar doxorubicin.
Cytotoxicity assay
A549 cells were maintained in RPMI 1640 medium 
supplemented with 10% fetal bovine serum and 1% 
penicillin-streptomycin at 37°C and in a humidified 5% CO2 
atmosphere. A549 cells were seeded in 96-well plates at a 
density of 3500 cells/well and allowed to grow overnight. 
On the following day, a set concentration of the various 
doxorubicin formulations was added into the culture medium. 
After 72 hours of incubation, the cytotoxic activity of 
doxorubicin was then evaluated using a standard MTT assay. 
Blank composite micelles were also tested for cell inhibition 
by MTT. All experiments were performed in triplicate. The 
results were calculated using the following equation:
Percentage cytotoxicity = [Absorbency (control group) 
  -   Absorbency (experiment group)]/Absorbency (  control 
group) × 100%
Fluorescent high-performance liquid 
chromatography
For evaluation of the accumulation and release of doxorubicin 
in A549 cells, a cell suspension containing the same 
concentration (2.5 µg/mL) of free doxorubicin or composite 
doxorubicin-loaded micelles, was seeded at a density of 
1 × 106 cells/mL in 2 mL of growth medium. To measure 
doxorubicin accumulation, cells were incubated for 4 hours. 
To detect released doxorubicin, cells were incubated with 
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doxorubicin for 4 hours, then the medium was removed and 
the cells were washed three times with phosphate-buffered 
saline. Fresh complete medium was then added and the 
cells were harvested one hour and 2.5 hours later. At each 
time point for measurement of accumulation and release of 
doxorubicin, the medium was removed, the cells were washed 
three times using ice-cold phosphate-buffered saline to 
remove noninternalized doxorubicin, and were subsequently 
resuspended in water (1 mL) and treated by probe-type 
ultrasonication 20 times (4°C, 200 W, active every 2 seconds 
for a duration of 5 seconds) to obtain the cell lysate. The 
lysate was centrifuged at 10,000 rpm for 5 minutes in a 
microcentrifuge (Hettich Zentrifugen, D-78532, Tuttlingen, 
Germany) to remove the cellular debris. The supernatant 
was analyzed by high-performance liquid chromatography 
(Agilent 1100) equipped with a multiwavelength fluorescence 
detector (excitation 488 nm and emission 570 nm). Calibration 
curves of known concentrations of doxorubicin in water were 
used for quantification. The chromatographic column used 
was an Agilent Zorbax Extend C18 (4.6 × 250 mm, 5 µm), 
and the mobile phase used was acetonitrile/0.015 M NaH2PO4 
solution (pH 4.5, 30:70), with the flow rate kept at 1.0 mL 
per minute.
Confocal laser scanning microscopy
Three-dimensional A549 multicellular spheroids were plated 
into 96-well culture dishes (Corning, NY) and identical 
concentrations of either free doxorubicin or composite 
doxorubicin-loaded micelles were added to the multicellular 
spheroids and incubated for 4 hours. The medium was then 
removed, the multicellular spheroids were washed with cold 
phosphate-buffered saline, and fresh complete medium was 
then added and the intensity of doxorubicin fluorescence 
and penetration was examined under a confocal laser 
scanning microscope (Zeiss LSM 510, Zurich, Switzerland) 
to determine the accumulation and release of the drug. 
Doxorubicin excitation and emission occurred at 485 nm 
and 595 nm, respectively.
Flow cytometry analysis
The intensity of doxorubicin fluorescence in the multicellular 
spheroids was determined by flow cytometry (FACSCalibur, 
Becton-Dickinson, Franklin Lakes, NJ). A549 spheroids 
were trypsinized, blown into a single cell suspension, and 
seeded into 24-well culture dishes at a density of 5 × 105 
cells/well. The same concentration (2.5 µg/mL) of composite 
doxorubicin-loaded micelles or free doxorubicin was added 
to the culture medium, taking the efficiency of doxorubicin 
loading into composite micelles into account. Cells were 
harvested after 2 and 3 hours to measure accumulation of 
doxorubicin. To detect the amount of doxorubicin released, 
the cells were incubated with doxorubicin for 3 hours, the 
medium was then removed, and the cells were washed three 
times with phosphate-buffered saline. Fresh complete medium 
was then added, and the cells were harvested 2 hours and 
4 hours later. At each time point, the medium was removed, 
the cells were washed three times with phosphate-buffered 
saline, and incorporation of doxorubicin was determined by 
fluorescence (488 nm excitation and 585 nm emission). Data 
were analyzed using FlowJo7.6 software.
Cell irradiation
Cell irradiation was performed using a medical linear accel-
erator (Primus-M, Siemens, Germany). The radiation field, 
dose rate, and source-to-cell distance were 40 cm × 40 cm, 
2 Gy per minute, and 100 cm, respectively.
Ionizing radiation and colony-forming 
assay
A549 multicellular spheroids were exposed to 2.5 µg/mL 
blank composite micelles, doxorubicin composite micelles 
(MIX), or free doxorubicin for 4 hours. The multicellular 
spheroids were then trypsinized, counted, and seeded into 
6-well culture dishes, irradiated (at 0–6 Gy), and incubated 
for a further 10 days. After this time, the cell colonies were 
washed with cold phosphate-buffered saline, fixed with 75% 
methanol, and stained with 0.5% crystal violet. Colonies 
containing more than 50 cells were counted using a dissecting 
microscope and cell survival curves were generated using 
GraphPad Prism 5.0 (GraphPad Software Inc, La Jolla, CA) 
based on the multitarget/single-hit model:
S = 1 - (1 - e-D/D0)N (L-Q)
and D0 was then calculated.
Cell migration
Multicellular spheroids with a diameter of approximately 
250 µm were chosen for these experiments because 
multicellular spheroids of this size do not undergo central 
necrosis and contain very few hypoxic cells.28 Each treatment 
group (sham, irradiation alone, blank composite micelle + 
irradiation, free doxorubicin + irradiation, and composite 
doxorubicin-loaded micelle + irradiation) consisted of 
30 individual A549 multicellular spheroids in five independent 
replicate experiments. The multicellular spheroids were 
incubated with or without the drug for 4 hours, the drugs 
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were then removed, the multicellular spheroids were washed 
twice with phosphate-buffered saline, and fresh complete 
medium was added. The individual multicellular spheroids 
were then plated into 6-well culture dishes without base-coated 
agarose. Under these conditions, the multicellular spheroids 
disassembled and released cells which migrated away from the 
central point. The area covered by migrated cells was measured 
in mm2 every 24 hours for 4 days, and the migration capability 
was estimated by the total area covered by the cells. The 
spheroid migration rate was calculated using the formula:
[1 - (The mean spheroid migration area of test group/ 
    The mean spheroid migration area of control group)] 
× 100%.
Proliferation assay
Multicellular spheroids with diameters of approximately 
250 mm were plated into 6-well culture dishes coated with 5% 
agarose. Each treatment group (sham, irradiation alone, blank 
composite micelle + irradiation, free doxorubicin + i  rradiation, 
and composite doxorubicin-loaded micelle + irradiation) con-
sisted of 30 individual A549 multicellular spheroids in five 
independent replicate experiments. To study the response to 
treatment, the multicellular spheroids were observed for 9 days, 
with monitoring of their growth every second day. Spheroid 
volume was calculated using the equation:
V = (4/3)πR3  R = (D1 + D2)/4
where D1 and D2 are the maximal diameters of multicellular 
spheroids measured in the rectangular direction. A statistical 
comparison of the original data was performed using an unpaired 
sample t-test following analysis of variance. P values ,0.05 
were considered to be statistically significant. The proliferation 
rate of the spheroids was calculated using the formula:
[1 - (Mean spheroid proliferation volume of test group/ 
    Mean spheroid proliferation volume of control group)]  
× 100%.
Results
Properties of composite doxorubicin-
loaded micelles
Transmission electron microscopy revealed that the 
  composite PEG-PCL/P105 micelles were spherical, with a 
uniform particle size distribution of approximately 20 nm, 
calculated using the mean diameter (number distribution). 
The entrapment efficiency of doxorubicin was 56.7% ± 1.8%. 
The critical micelle concentration, ie, the concentration of 
surfactants above which micelles form and for which almost 
all additional surfactants are incorporated into micelles, was 
determined by the fluorescence intensity ratio (I338/I333) 
using pyrene as a fluorescent probe and calculated to be 
0.98 µg/mL and 0.92 µg/mL for PEG-PCL (EG/CL 7.08) 
micelles and Pluronic 105 micelles, respectively.
Cytotoxicity of different doxorubicin  
in A549 cells
The cytotoxicity of free doxorubicin, the blank composite 
micelles, and the composite doxorubicin-loaded micelles in 
A549 cells was evaluated. As shown in Figure 1, the composite 
doxorubicin-loaded micelles showed notable improvement 
of cytotoxicity compared with free doxorubicin. The blank 
composite micelles rarely caused cell death, indicating that 
any cytotoxicity was caused by doxorubicin rather than the 
carrier material.
More cellular uptake and sustained 
release of doxorubicin-loaded micelles
Internalization of composite doxorubicin-loaded micelles and 
free doxorubicin in the A549 tumor cells was examined by 
fluorescent high-pressure liquid chromatography. As shown 
in Figure 2, after 4 hours of incubation, envelopment of 
doxorubicin in the composite micelles significantly increased 
cellular accumulation of the drug. After treatment with 
composite doxorubicin-loaded micelles or free doxorubicin 
for 4 hours, followed by one-hour recovery and 2.5-hour 
recovery periods, envelopment of doxorubicin in the 
composite micelles produced significantly sustained cellular 
release of the drug.
More cellular accumulation and slower 
release of doxorubicin-loaded micelles
Intracellular incorporation and release of doxorubicin in 
A549 multicellular spheroids was measured by confocal 
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Figure 1 Cytotoxicity determined by MTT assay in A549 cells. 
Notes: Cells were incubated with doxorubicin-loaded composite micelles, free 
doxorubicin, and blank composite micelles for 72 hours. 
Abbreviations: DOX, free doxorubicin; MIX, composite doxorubicin-loaded micelles.
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laser scanning microscopy (Figure 3). After 4 hours of 
incubation, A549 multicellular spheroids incubated with 
MIX (Figure 3B1) were more intensely fluorescent and 
showed deeper penetration of fluorescence than multicellular 
spheroids treated with free doxorubicin (Figure 3A1), which 
had barely detectable levels of intracellular   fluorescence. 
Only very weak fluorescence was observed for multicellular 
spheroids treated with free doxorubicin for 4 hours 
  followed by a one-hour recovery period (Figure 3A2). In 
contrast, multicellular spheroids treated with MIX were 
strongly   fluorescent one hour after withdrawal of the drug 
 ( Figure 3B2). Moreover, levels of fluorescence remained 
high at 2.5 hours (Figure 3B3).
More cellular uptake and slower release 
from doxorubicin-loaded micelles
Multicellular spheroid intracellular doxorubicin uptake and 
release by MIX and free doxorubicin was investigated by flow 
cytometry. As shown in Figure 4, after 2 and 3 hours, the 
intensity of cellular fluorescence was 14.14 and 13.61 times 
higher in MIX-treated multicellular spheroids than in free 
doxorubicin-treated multicellular spheroids for equivalent 
2.5 µg/mL drug treatments. For multicellular spheroids 
incubated with MIX or free doxorubicin that achieved the 
same amount of doxorubicin incorporation after 3 hours 
of exposure, the intensity of cellular fluorescence in MIX-
treated A549 cells at 2 and 4 hours following drug withdrawal 
was 9.53 and 14.93 times that of the free doxorubicin-treated 
cells, respectively (Figure 5). Overall, the quantitative 
results obtained by flow cytometry are in good agreement 
with those obtained by confocal laser scanning microscopy 
(Figure 3).
Colony formation assays
Cell survival curves are showed in Figure 6. D0s was 
1.466 Gy, 1.405 Gy, 1.230 Gy, and 1.020 Gy, respectively, 
for the groups that received irradiation only, blank composite 
micelles + irradiation, doxorubicin + irradiation, and MIX + 
irradiation, respectively. The sensitizing enhancement ratio 
of cells treated with equivalent amounts of free doxorubicin 
and doxorubicin-loaded micelles were 1.19 and 1.44, 
respectively (P , 0.05). There was no difference between 
the group receiving irradiation only and the group receiving 
blank composite micelles + irradiation.
Cell migration assays
Cell migration was determined for both treated and untreated 
spheroids. A significant growth reduction of 30% and 28%, 
respectively, was seen in the irradiation only group and the 
blank composite micelles + irradiation group after 4 days. 
There was no statistically significant difference between the 
irradiation only group and the blank composite micelles + 
irradiation group. However, combined treatment with 
equivalent concentrations of free doxorubicin or composite 
doxorubicin-loaded micelles had a significant additive 
effect on growth reduction of 46% and 61%, respectively 
(Figure 7).
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Figure 2 Intracellular doxorubicin in A549 cells. 
Notes: Doxorubicin uptake into A549 tumor cells after incubation with composite 
doxorubicin-loaded  micelles  or  free  doxorubicin  for  4  hours,  then  compounds 
removed for one hour and 2.5 hours. Accumulation 4 hours: A549 cells incubated 
in composite doxorubicin-loaded micelles or free doxorubicin for 4 hours; release 
one hour. A549 cells incubated in composite doxorubicin-loaded micelles or free 
DOX for 4 hours, then compounds removed for one hour; release 2.5 hours, 
A549 cells incubated in composite doxorubicin-loaded micelles or free doxorubicin 
for 4 hours, then compounds removed for 2.5 hours. 
Abbreviations: DOX, free doxorubicin; MIX, composite doxorubicin-loaded micelles.
Figure 3 Confocal laser scanning microscopy of cellular incorporation and release of 
doxorubicin in A549 multicellular spheroids. (A1) A549 spheroid cells incubated in free 
doxorubicin for 4 hours. (A2) Free doxorubicin released from the spheroid for one 
hour. (B1) A549 spheroid cells incubated in composite doxorubicin-loaded micelles 
with the same doxorubicin densities for 4 hours. (B2) Composite doxorubicin-loaded 
micelles released from the spheroid for one hour. (B3) Composite doxorubicin-
loaded micelles released from the spheroid for 2.5 hours.
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Figure 4 Flow cytometric histograms of A549 spheroid cells incubated with composite doxorubicin-loaded micelles or free doxorubicin with the same doxorubicin densities 
for 2 hours and 3 hours. DOX for 2 hours, multicellular spheroids incubated in free doxorubicin for 2 hours; DOX for 3 hours, multicellular spheroids incubated in free 
doxorubicin for 3 hours; MIX for 2 hours, multicellular spheroids incubated in MIX for 2 hours; MIX for 3 hours, multicellular spheroids incubated in MIX for 3 hours. 
Abbreviations: DOX, free doxorubicin; MIX, composite doxorubicin-loaded micelles.
01 02 103 104 105
Comp-PE-A::DOX
C
o
u
n
t
100
80
60
40
20
0
MIX for 4 h
MIX for 2 h
DOX for 2 h
DOX for 4 h
Control
Figure 5 Flow cytometric histograms of multicellular spheroids incubated with MIX or free doxorubicin that achieved the same doxorubicin incorporation after 3 hours of 
exposure, at 2 and 4 hours following drug withdrawal.
Notes: DOX for 2 hours, multicellular spheroids incubated in free doxorubicin for 3 hours, then compounds removed for 2 hours; DOX for 4 hours, multicellular spheroids 
incubated in free doxorubicin for 3 hours, then compounds removed for 4 hours; MIX for 2 hours, multicellular spheroids incubated in MIX for 3 hours, then compounds 
removed for 2 hours; MIX for 4 hours, multicellular spheroids incubated in MIX for 3 hours, then compounds removed for 4 hours. 
Abbreviations: DOX, free doxorubicin; MIX, composite doxorubicin-loaded micelles.
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Cell proliferation assays
The proliferation capacity of spheroids treated with equiva-
lent concentrations of doxorubicin or MIX was determined. 
Following irradiation alone and blank composite micelles + 
irradiation, the spheroids showed significant growth reduc-
tion of 44% and 47%, respectively, after 9 days. There was 
no difference between the irradiation only group and the 
blank composite micelles + irradiation group. However, 
following combined treatment, the spheroids showed signifi-
cantly increased growth reduction of 58% (for radiation + 
free doxorubicin) and 77% (for radiation + MIX) after nine 
days (Figure 8).
Discussion
Radiotherapy is very effective for local control of tumors, but 
its curative potential is limited by the intrinsic radioresistance 
of most malignant tumor cells, which often leads to treatment 
failure. New strategies, such as developing radiosensitiz-
ers, are clinically important and have become an important 
research focus.
Doxorubicin is a tetracycline antibiotic commonly used 
in the treatment of cancer19 and induces DNA damage by 
inhibition of topoisomerase II and free radical generation 
as an anticancer mechanism.20 Doxorubicin can also bind 
covalently to DNA, leading to formation of doxorubicin-
DNA adducts and interstrand cross-links. For these reasons, 
doxorubicin is the antitumor drug most widely used for 
enhancement of radiotherapy. The mechanism of doxorubicin-
mediated radiosensitization may include induction of tumor 
cell apoptosis, and an increase in both sublethal radiation-
induced damage and DNA repair processes.
However, in addition to its low solubility in water, 
doxorubicin has severe side effects, including acute toxicity 
to normal tissue, and its therapeutic effects can be minimized 
by the inherent multidrug resistance of many tumor cells.21 To 
reduce the acute toxicity of free doxorubicin and to improve 
its therapeutic efficacy, various polymeric micelle systems 
have been designed as delivery vehicles.22–24 Studies have 
shown that cellular uptake of doxorubicin-loaded micelles 
and free doxorubicin are very different, ie, doxorubicin 
micelles are transported into cells by endocytosis, whereas 
free doxorubicin enters cells by simple diffusion.18
In this study, we prepared composite PEG-PCL and 
P105 micelles using the solvent evaporation method to serve 
as carriers for doxorubicin. This method produces a relatively 
small particle size distribution, due to the low molecular 
weight and high hydrophilicity of P105. We successfully 
established three-dimensional A549 multicellular spheroids 
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that are a more physiologically relevant model of lung cancer 
than monolayer cells, because they resemble the architecture 
of in vivo tumors17,25,26 and can recapitulate in vivo processes 
which may affect drug performance, such as cell-cell contact, 
variations in the cell cycle, altered metabolism, and diffusion 
of nutrients, oxygen, or drugs.17,25,27,28 Multicellular spheroids 
are relatively easy to produce and maintain in culture, and 
treatment-related changes in spheroid growth kinetics and 
tumor cell outgrowth are established and reproducible 
endpoints.17,25,29 As a consequence of their particular archi-
tectural characteristics, multicellular spheroids have been 
demonstrated to be extremely useful for testing radiotherapy 
protocols.30
We studied the doxorubicin sensitization mechanism 
in a number of experiments. First, we used MTT to study 
the cytotoxicity of different doxorubicin formulations in 
A549 cells. As shown in Figure 1, composite doxorubicin-
loaded micelles showed notable improvement in cytotoxicity 
compared with free doxorubicin. Blank composite micelles 
rarely caused cell death, indicating that cytotoxicity was 
caused by doxorubicin rather than by the carrier material. 
Internalization of composite doxorubicin-loaded micelles and 
free doxorubicin into A549 tumor cells was then examined 
by fluorescent high-performance liquid chromatography. As 
shown in Figure 2, after 4 hours of incubation, envelopment 
of doxorubicin in the composite micelles significantly 
increased intracellular accumulation of the drug. After 
treatment with composite doxorubicin-loaded micelles or free 
doxorubicin for 4 hours, followed by a one-hour recovery 
or 2.5-hour recovery period, envelopment of doxorubicin in 
the composite micelles sustained cellular release of the drug 
in a significant manner.
We also undertook a series of experiments in A549 multi-
cellular spheroids, in which we investigated accumulation and 
efflux of doxorubicin by confocal laser scanning microscopy. 
As shown in Figure 3, after 4 hours, A549 multicellular 
spheroids incubated with MIX showed a greater fluorescent 
intensity and deeper penetration than those treated with free 
doxorubicin, in which intracellular fluorescence was barely 
detectable. In contrast, high levels of fluorescence were still 
detectable in MIX-treated spheroids 2.5 hours after drug 
withdrawal, indicating that use of composite doxorubicin-
loaded micelles leads to improved cellular retention of 
doxorubicin.
By measuring the intensity of fluorescence and depth 
of doxorubicin penetration into multicellular spheroids, we 
found that treatment with doxorubicin-loaded micelles led 
to higher intracellular accumulation and deeper penetration 
than that obtained for free doxorubicin. In addition, the use 
of micelle carriers led to a longer doxorubicin retention 
time in multicellular spheroids. Our previous study13 also 
showed rapid efflux of free doxorubicin from K562/ADR 
cells. However, unlike doxorubicin in solution, uptake of 
composite doxorubicin-loaded PEG-PCL/P105 micelles 
occurs via endocytosis. Micelles enter cells slowly, avoid 
being pumped out, and continue to accumulate around the 
cell nucleus. Similar results were obtained by Shuai et al,18 
who reported that free doxorubicin was rapidly pumped out 
of cells, but that micelle carriers inhibited doxorubicin efflux 
and improved retention in cells.
Furthermore, quantitative flow cytometry studies verified 
that, for equivalent doxorubicin concentrations, composite 
doxorubicin-loaded micelles significantly enhanced cellular 
doxorubicin accumulation and inhibited doxorubicin release. 
Doxorubicin uptake in MIX-treated multicellular spheroids 
was 14.14 and 13.61 times greater than in multicellular 
spheroids treated with free doxorubicin after 2 hours and 
3 hours, respectively. In addition, doxorubicin retention was 
9.53 and 14.93 times greater in MIX-treated multicellular 
spheroids than in multicellular spheroids treated with an 
equivalent concentration of free doxorubicin 2 and 4 hours, 
respectively, after drug withdrawal. Overall, our quantitative 
results (shown in Figures 4 and 5) agree with those obtained 
by confocal laser scanning microscopy (Figure 3), and 
suggest that doxorubicin binding to the hydrophobic core 
of the micelle may prevent its efflux.
Colony-forming assays also demonstrated that composite 
doxorubicin-loaded micelles are radiosensitive, as shown by 
significantly reduced survival of cells treated by radiation + 
composite micelles compared with those treated with radia-
tion + free doxorubicin, radiation alone, or radiation + blank 
composite micelles. The surviving fraction of cells treated 
with MIX + radiation was significantly lower than for cells 
subject to irradiation alone or radiation + blank composite 
micelles (P , 0.05). However, there was no statistically 
significant difference in cell death between cells treated with 
a combination of free doxorubicin + irradiation relative to 
irradiation alone or radiation + blank composite micelles.
Finally, the cellular migration area and growth capability 
of multicellular spheroids confirmed the increased radiosen-
sitivity of cells treated with composite doxorubicin-loaded 
micelles compared with those treated with free doxorubicin. 
In short, we successfully increased the radiosensitivity of 
A549 multicellular spheroids using composite micelles 
loaded with doxorubicin. At equivalent drug concentrations, 
composite doxorubicin-loaded PEG-PCL/P105 micelles 
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significantly enhanced the accumulation of doxorubicin in 
multicellular spheroids and inhibited release of doxorubicin 
from multicellular spheroids, thus achieving improved 
radiosensitivity. Preventing a burst of doxorubicin release 
may avoid excessive damage to normal tissue, minimizing 
cytotoxic effects. Therefore, this study provides a novel 
approach to improving radiosensitivity of tumor cells, and 
may achieve an improved therapeutic outcome for cancers 
that cannot be well controlled by traditional radiotherapy. 
Clinical application of this research may reduce the side 
effects of conventional cancer therapies, and thereby improve 
patient compliance.
In summary, composite doxorubicin-loaded micelles 
consisting of PEG-PCL/Pluronic P105 can significantly 
enhance doxorubicin radiosensitivity in lung cancer 
multicellular spheroids and provide a novel approach to 
lung cancer treatment. Further similar investigations should 
be undertaken in other tumor models. Further, combined 
treatment with micelle-encapsulated doxorubicin and 
radiation therefore warrants investigation in clinical trials 
as a potential anticancer strategy.
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